Data suggests that the introduction of the topical fourth-generation fluoroquinolones is reducing the occurrence rate of endophthalmitis in ophthalmic surgery patients.
As research and technology continues to evolve, practitioners are faced with the challenge of successfully retaining contact lens wear while prescribing ophthalmic medication therapy.
Choosing the right solution can impact patient compliance with the lens care regimen, ocular health and patient satisfaction with their contact lenses.
This year’s ARVO meeting explores novel research and best practices in the fields of lens and storage case biofilms, lens bioburden and associated adverse events.
